Peter O. Kwiterovich

Johns Hopkins University — United States

Medicine · Health Sciences

62h-index15.6kcitations244works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(120), Diabetes, Cardiovascular Risks, and Lipoproteins(101), Lipid metabolism and disorders(37), Cancer, Lipids, and Metabolism(36), Cholesterol and Lipid Metabolism(33)

Publications244 total

Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia
The Journal of Pediatrics·2015· 69 cited
Detection and Treatment of Children and Adolescents with Dyslipidemia
Contemporary Endocrinology·2015· 1 cited
A Double-Blind Randomized Trial of Fish Oil to Lower Triglycerides and Improve Cardiometabolic Risk in Adolescents
The Journal of Pediatrics·2014· 55 citedOpen Access
DOES LOW HDL-C INCREASE CHD RISK WHEN TG & LDL-C ARE NORMAL? THE FRAMINGHAM OFFSPRING STUDY
Journal of the American College of Cardiology·2014· 1 cited
Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
JAMA·2013· 820 citedOpen Access
Very Large Database of Lipids: Rationale and Design
Clinical Cardiology·2013· 41 citedOpen Access
Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes
Journal of the American College of Cardiology·2013· 310 citedOpen Access
Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults
Journal of the American College of Cardiology·2013· 69 cited
Menstrual and reproductive characteristics and breast density in young women
Cancer Causes & Control·2013· 29 citedOpen Access
Response to the letter from Okada et al
Journal of clinical lipidology·2013
Diagnosis and Management of Familial Dyslipoproteinemias
Current Cardiology Reports·2013· 14 cited
Efficacy and Safety of Ezetimibe Monotherapy in 6-10 Year Old Children with Heterozygous Familial or Non-familial Hypercholesterolemia
Journal of clinical lipidology·2013
Update on the detection and treatment of atherogenic low-density lipoproteins
Current Opinion in Endocrinology Diabetes and Obesity·2013· 19 cited
Author's Response Universal Lipid Screening: In Response to Ongoing Debate
PEDIATRICS·2013· 6 cited
Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
Journal of the American College of Cardiology·2013· 412 cited
EFFICACY AND SAFETY OF EZETIMIBE MONOTHERAPY IN CHILDREN SIX TO TEN YEARS OF AGE WITH HETEROZYGOUS FAMILIAL OR NON-FAMILIAL HYPERCHOLESTEROLEMIA
Journal of the American College of Cardiology·2013· 1 cited
Diagnosis and Treatment of Dyslipoproteinemias in Children and Adolescents
Pediatric Endocrinology·2013· 3 cited
Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2–3 months of age and their parents
Journal of clinical lipidology·2012· 7 cited
Universal Screening of Cholesterol in Children
Clinical Cardiology·2012· 21 citedOpen Access
Guidelines for Lipid Screening in Children and Adolescents: Bringing Evidence to the Debate
PEDIATRICS·2012· 40 cited
page 1 of 13Next →

Frequent Co-authors

Allan D. Sniderman(6), Thomas A. Pearson(6), Bruce Barton(6), Linda Van Horn(6), Sue Y.S. Kimm(5), Denise G. Simons‐Morton(5), Sally Hunsberger(5), Norman L. Lasser(5), Frank A. Franklin(5), Ronald M. Lauer(5), Alan M. Robson(4), Victor J. Stevens(4), Paul S. Bachorik(4), Roger S. Blumenthal(3), Ba‐Bie Teng(3), Ronald M. Krauss(3), Eva Obarzanek(3), Merwyn R. Greenlick(3), Basil M. Rifkind(3), Robert P. McMahon(3)